Download PDF
Thromb Haemost 1982; 48(03): 339-340
DOI: 10.1055/s-0038-1657295
Letter to the Editor
Schattauer GmbH Stuttgart

Disseminated Intravascular Coagulation After Infusion of FEIBA (Factor VIII Inhibitor Bypassing Activity) in a Patient with Acquired Haemophilia

F Rodeghiero
Divisione di Ematologia, Ospedale Regionale di Vicenza, Italy
,
S Castronovo
Divisione di Ematologia, Ospedale Regionale di Vicenza, Italy
,
E Dini
Divisione di Ematologia, Ospedale Regionale di Vicenza, Italy
› Author Affiliations
Further Information

Publication History

Received 27 July 1982

Accepted 31 August 1982

Publication Date:
13 July 2018 (online)

  PDF Download  Permissions and Reprints
 

  • References

  • 1 Blatt MF, Ménaché D, Roberts HR. A survey of the effectiveness of prothrombin complex concentrates in controlling haemorrhage in patients with haemophilia and anti-factor VIII antibodies. Thromb Haemostas 1980; 44: 39-42
    PubMedGoogle Scholar
  • 2 Abildgaard CF. Hazards of prothrombin-complex concentrates in treatment of hemophilia. N Engl J Med 1981; 304: 670-671
    PubMedGoogle Scholar
  • 3 Stenbjerg S, Jorgensen J. Disseminated intravascular coagulation and infusion of factor VIII inhibitor bypassing activity. Lancet 1977; 1: 360
    PubMedGoogle Scholar
  • 4 Rai K, Sawitsky A, Eugene P, Chanana AD, Levy RN, Pasternack BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219-234
    CrossrefPubMedGoogle Scholar